WebOct 24, 2024 · TEGSEDI REMS Program. Because of the risks of serious bleeding caused by severe thrombocytopenia and because of glomerulonephritis, both of which require frequent monitoring, TEGSEDI is available only through a restricted distribution program under a Risk Evaluation and Mitigation Strategy ... Webdiscontinued TEGSEDI *The REMS will send a reminder to the certified prescriber of record when the . Patient Status Form . is due. Completed forms should be submitted to the TEGSEDI REMS online at . www.TEGSEDIrems.com . or via fax to 1-855-483-4736. Pharmacy Requirements . Become Certified Ensure Compliance with REMS …
TEGSEDI REMS
WebBecause of the risk of serious bleeding caused by low platelet counts and because of the risk of kidney problems, TEGSEDI is available only through a restricted program called the TEGSEDI Risk Evaluation and Mitigation Strategy (REMS) Program. Talk to your healthcare provider about how to enroll in the TEGSEDI REMS Program. WebTEGSEDI is a medicine that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis. TEGSEDI is for use in adults only. Important Safety Information. … caravan fitzrovia 152 great portland street
TEGSEDI REMS Program Overview (Risk Evaluation and …
WebBecause of the risk of serious bleeding caused by low platelet counts and because of the risk of kidney problems, TEGSEDI is available only through a restricted program called the TEGSEDI Risk Evaluation and Mitigation Strategy (REMS) Program. Talk to your healthcare provider about how to enroll in the TEGSEDI REMS Program. WebJul 27, 2024 · REMS. Because of the risk of serious bleeding from thrombocytopenia and the risk of glomerulonephritis, inotersen is available only through a restricted distribution program called the Tegsedi REMS program. Information about the Tegsedi REMS program is available at 844-483-4736 or at . Administration. Administer by sub-Q injection only. WebTEGSEDI® REMS This form must be completed for all patients treated with TEGSEDI as follows: •Every 90 days following the first dispense of TEGSEDI treatment •At discontinuation of TEGSEDItreatment •At 8 weeks following discontinuation of TEGSEDI treatment (this is the final 8 week Patient Status Form) broadus mt. weather